One of the first Alzheimer’s patients in the Lowcountry to take part in Leqembi infusion treatments is sharing his story in ...
Medicare will cover new class of Alzheimer's drugs if fully approved by FDA, with limits Jun 2, 2023 The real costs of the new Alzheimer's drug, most of which will fall to taxpayers Aug 14, 2023 ...
Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover the drug, I have met with Alzheimer’s patients and their loved ones who are anxious to ...
The EU recommends Anavex proceed with a full approval application for Alzheimer's drug Blarcamesine based on full Phase 2b/3 trial data. The U.S. FDA may grant accelerated approval to Anavex's ...
A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer's dementia.
FDA approves much-debated Alzheimer’s drug panned by experts June 8, 2021 Alzheimer’s drug from Eisai and Biogen slows cognitive decline, side-effects in focus November 30, 2022 Panel: More ...
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
New treatments and tests for dementia are finally here, after decades of disappointments The post Dementia Breakthroughs ...
A small pharmaceutical company in Research Triangle Park is considering its next steps after seeing positive results in a clinical study evaluating its treatment for Alzheimer's disease.
Just four months after the Food and Drug Administration gave full approval to a new Alzheimer’s drug, it’s estimated that ...
TAMPA, Fla. — November is Alzheimer's Awareness Month. It's estimated that 1 in 8 Floridians are currently living with the disease and are supported by more than 800,000 unpaid family caregivers.
When my friend Ira was diagnosed with Pancreatic cancer he went through surgery and chemotherapy, but was still facing a short life expectancy. Then he was lucky to be 1 of only 26 patients in an ...
